학술논문
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Document Type
Article
Author
Voci, D.; Fumagalli, R.M.; Roth-Zetzsche, S.; Sebastian, T.; Kucher, N.; Barco, S.; Götschi, A.; Held, U.; Bingisser, R.; Simon, N.R.; Colucci, G.; Duerschmied, D.; Gerber, B.; Hasse, B.; Keller, D.I.; Konstantinides, S.V.; Mach, F.; Rampini, S.K.; Righini, M.; Robert-Ebadi, H.; Rosemann, T.; Spirk, D.; Stortecky, S.; Vaisnora, L.
Source
In: Thrombosis Research . (Thrombosis Research, January 2023, 221:157-163)
Subject
Language
English
ISSN
18792472
00493848
00493848